The UK Faculty of Public Health has recently taken ownership of the Health Knowledge resource. This new, advert-free website is still under development and there may be some issues accessing content. Additionally, the content has not been audited or verified by the Faculty of Public Health as part of an ongoing quality assurance process and as such certain material included maybe out of date. If you have any concerns regarding content you should seek to independently verify this.

References

Health Economics: References

 

  • Appleby J, Devlin N, Parkin D (2007) NICE's cost effectiveness threshold. British Medical Journal, 25;335(7616):358-9.
     
  • Begg,D., Fischer,S., Dornbusch,R.(2003) Economics, London, McGraw-Hill
     
  • Black, W.C. (1990). The cost-effectiveness plane: a graphic representation of cost-effectiveness. Medical Decision Making, 10, 212-5
     
  • Briggs, A., Sculpher, M. and Claxton, K. (2006) Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press.
     
  • Brooks R. (1996) EuroQoL: the current state of play. Health Policy; 37:53-72
     
  • Buxton M.J., Drummond, M.F., van Hout, B., Prince, R.L., Sheldon, T.A., Szucs, T., Vray, M. (1997). Modelling in economic evaluation: an unavoidable fact of life. Health Economics, 6, 217-27.
     
  • Byford S, Torgerson DJ, Raftery J. (2000) Economic Note: Cost of illness studies. British Medical Journal 320: 1335.
     
  • Dakin, H, Devlin, N, Feng, Y, Rice, N, O'Neill, P, and Parkin, D. (2015) The Influence of Cost-Effectiveness and Other Factors on NICE Decisions. Health Economics, 24, 1256–1271. doi: 10.1002/hec.3086.
     
  • Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35(11):1095-1108.
     
  • Davis, K., Stremikis, K, Schoen, C and Squires, D. (2014) Mirror, Mirror on the Wall Update: How the U.S. Health Care System Compares Internationally. The Commonwealth Fund, June 2014.
     
  • Drummond, M.F., Sculpher, M.J., Claxton, K., Stoddart, G.L. and Torrance, G.W. (2015) Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press
     
  • Halpern, M.T., McKenna, M., Hutton, J. (1998). Modelling in economic evaluation: An unavoidable fact of life. Health Economics, 7, 741-742.
     
  • Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., Badia, X. (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10): 1727–1736. DOI: 10.1007/s11136-011-9903-x
     
  • HM Treasury (Multiple years).  The Green Book: Appraisal and Evaluation in Central Government
     
  • Hollingsworth, B., Peacock, S. (2008) Efficiency Measurement in Health and Heath Care. Routledge.
     
  • Knapp, M. (1984) The Economics of Social Care (Studies in Social Policy), Macmillan
     
  • McIntyre, D., Mooney G. (2007) The Economics of Health Equity. Cambridge University Press.
     
  • Mauskopf J., Rutten F, Schonfeld W. (2003) Cost-Effectiveness League Tables: Valuable Guidance for Decision Makers? PharmacoEconomics, 21:991-1000
     
  • Mitton, C. Donaldson, C. (2001) Twenty-five years of programme budgeting and marginal analysis in the health sector, 1974-1999. J Health Services Research and Policy, 6:239-248
     
  • Morris, S., Devlin N., Parkin. D., Spencer, A. (2012). Economic Analysis in Health Care, 2nd Edition. London, Wiley
     
  • Murray, Christopher J L et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet , Volume 380 , Issue 9859 , 2197 - 2223
     
  • O’Donnell, O., van Doorslaer, E., Wagstaff, A., Lindelow, M. (2008) Analyzing Health Equity Using Household Survey Data. World Bank Publications.
     
  • Szende, A., Oppe, M. and Devlin, N. (Editors) (2007) EQ-5D Value Sets: Inventory, Comparative Review and User Guide, Springer Verlag.
     
  • Van Hout, B. A., Al, M. J., Gordon, G. S., et al (1994) Costs, effects and C/E-ratios alongside a clinical trial. Health Economics, 3, 309-319.

 

 

 

© David Parkin 2017